MAMO.CZ | MAMO SCREENING [ISSN 1804-0861]
česky | english | Site map

News

Epidemiology of breast cancer in the Czech Republic Epidemiology of breast cancer Classification of findings in mammography screening Classification of findings in mammography screening Specialized centres Specialized centres
3D breast screens improve detection and reduce false positives

Three-dimensional (3D) breast screens (mammograms) could offer substantial improvements in cancer detection and reducing false positives when used in conjunction with traditional two-dimensional (2D) mammograms, according to the results of a new study published in The Lancet Oncology.

25.4.2013 ecancer.org | More information...
Scientists find promising new target for aggressive breast cancer

Women with triple-negative breast cancer are more likely to have high levels of the MET biomarker in their tumours, making it a good new target for cancer drugs according to research published in the British Journal of Cancer, today (Wednesday).

20.3.2013 British Journal of Cancer Press Release | More information...
Study examines outcomes of screening mammography for age, breast density, hormone therapy

A study that compared the benefits and harms of the frequency of screening mammography to age, breast density and postmenopausal use of hormone therapy (HT) suggests that woman aged 50 to 74 years who undergo biennial screenings have a similar risk of advanced-stage disease and a lower cumulative risk of false-positive results than those who get mammograms annually, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.

18.3.2013 JAMA Press Release | More information...
Blood test reveals women's response to breast cancer treatment

Breast tumour DNA circulating in the bloodstream could be used to measure how well a woman’s cancer is responding to treatment, according to a new Cancer Research UK study published in the New England Journal of Medicine.

13.3.2013 Cancer Research UK Press Release | More information...
APOBEC3B is an enzymatic source of mutation in breast cancer

Genetic errors driving the majority of breast cancers may be caused by a hyperactive enzyme called APOBEC3B, according to US researchers.

8.2.2013 Cancer Research UK | More information...

Archive